Annexon, Inc.

ANNX · Nasdaq · SIC 2834: Pharmaceutical Preparations
109
SEC Filings

Business Summary

PART I Item 1. Bu siness. In this Annual Report on Form 10-K, we, our, us, Annexon and the Company refer to Annexon, Inc. and its consolidated subsidiary. Annexon, Annexon, Inc., the Annexon logo and other trade names, trademarks or service marks of Annexon are the property of Annexon, Inc. This report contains references to our trademarks and to trademarks belonging to other entities. Trade names, trademarks and service marks of other companies appearing in this report are the property of their...

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionANNXdiscussed_in_filing Cybersecurity
topic_mentionANNXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-131782EDGAR83K words
2025-03-032024-12-310000950170-25-030849EDGAR—
2024-03-262023-12-310000950170-24-036408EDGAR—
2023-03-062022-12-310000950170-23-006232EDGAR—
2022-03-012021-12-310001564590-22-008044EDGAR—
2021-03-252020-12-310001564590-21-015262EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-274240EDGAR57K words
2025-08-142025-06-300000950170-25-108869EDGAR—
2025-05-122025-03-310000950170-25-069200EDGAR—
2024-11-142024-09-300000950170-24-127057EDGAR—
2024-08-122024-06-300000950170-24-095401EDGAR—
2024-05-132024-03-310000950170-24-058659EDGAR—
2023-11-132023-09-300000950170-23-062913EDGAR—
2023-08-072023-06-300000950170-23-039054EDGAR—
2023-05-082023-03-310000950170-23-018797EDGAR—
2022-11-032022-09-300000950170-22-021509EDGAR—
2022-08-082022-06-300000950170-22-015560EDGAR—
2022-05-092022-03-310000950170-22-008494EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-131746EDGAR3K words
2026-02-170001193125-26-054695EDGAR—
2026-01-140001193125-26-012918EDGAR—
2026-01-120001193125-26-009740EDGAR—
2025-11-140001193125-25-283191EDGAR—
2025-11-100001193125-25-274220EDGAR—
2025-08-140000950170-25-108859EDGAR—
2025-06-250001193125-25-147005EDGAR—
2025-06-090001193125-25-137810EDGAR—
2025-05-120000950170-25-069156EDGAR—

109 total filings indexed. 81 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001528115
TickerANNX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c9cb8e1155da3e84f4f81d2a745a6110894c55d65944d4dd1ee75f8a2806a665
parent: 4390e5f9e8fda7624eee264f235b1012c133b94d62082d8b9d1990745c45acec
content hash: de319f686ccb7ade29480ec7104c86cf2e4a0e011b83338ead53a95fc0246bdb
signed: 2026-04-13T04:43:39.741Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf